Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Clinical Studies
  • View Item
  • Home
  • ICR Divisions
  • Clinical Studies
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria

Thumbnail
Publication Date
2008-03
ICR Author
Matutes, Estella
Author
Matutes, E
Oscier, D
Montalban, C
Berger, F
Callet-Bauchu, E
Dogan, A
Felman, P
Franco, V
Iannitto, E
Mollejo, M
Papadaki, T
Remstein, ED
Salar, A
Sole, F
Stamatopoulos, K
Thieblemont, C
Traverse-Glehen, A
Wotherspoon, A
Coiffier, B
Piris, MA
Type
Journal Article
Metadata
Show full item record
Abstract
Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an increasing number of publications have dealt with multiple aspects of SMZL diagnosis, molecular pathogenesis and treatment. This process has identified multiple inconsistencies in the diagnostic criteria and lack of clear guidelines for the staging and treatment. The authors of this review have held several meetings and exchanged series of cases with the objective of agreeing on the main diagnostic, staging and therapeutic guidelines for patients with this condition. Specific working groups were created for diagnostic criteria, immunophenotype, staging and treatment. As results of this work, guidelines are proposed for diagnosis, differential diagnosis, staging, prognostic factors, treatment and response criteria. The guidelines proposed here are intended to contribute to the standardization of the diagnosis and treatment of these patients, and should facilitate the future development of clinical trials that could define more precisely predictive markers for histological progression or lack of response, and evaluate new drugs or treatments.
URL
https://repository.icr.ac.uk/handle/internal/2448
Collections
  • Clinical Studies
  • Molecular Pathology
Version of record
10.1038/sj.leu.2405068
Research team
Molecular Haematology (including Cytogenetics Group and Cell Markers)
Language
English
License start date
2008-03
Citation
LEUKEMIA, 2008, 22 pp. 487 - 495
Publisher
NATURE PUBLISHING GROUP

Browse

All of ICR repositoryICR DivisionsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.